Haemonetics Corp (HAE)
85.55
+0.67
(+0.79%)
USD |
NYSE |
Apr 18, 11:33
Haemonetics Price: 85.55 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 17, 2024 | 84.26 | 85.45 | 84.06 | 84.88 | 359409.0 |
| Apr 16, 2024 | 84.36 | 84.92 | 83.64 | 84.17 | 273091.0 |
| Apr 15, 2024 | 85.39 | 86.24 | 84.86 | 84.88 | 318187.0 |
| Apr 12, 2024 | 85.98 | 86.22 | 84.67 | 85.22 | 395113.0 |
| Apr 11, 2024 | 86.80 | 86.80 | 85.82 | 86.52 | 402449.0 |
| Apr 10, 2024 | 86.25 | 87.34 | 85.64 | 86.15 | 398286.0 |
| Apr 09, 2024 | 85.89 | 87.11 | 85.67 | 87.06 | 307288.0 |
| Apr 08, 2024 | 84.90 | 85.58 | 84.61 | 85.32 | 234853.0 |
| Apr 05, 2024 | 84.76 | 85.29 | 84.24 | 84.65 | 272372.0 |
| Apr 04, 2024 | 84.73 | 86.04 | 84.44 | 84.89 | 384690.0 |
| Apr 03, 2024 | 83.67 | 84.69 | 83.23 | 83.92 | 532896.0 |
| Apr 02, 2024 | 83.58 | 85.08 | 83.13 | 84.17 | 510381.0 |
| Apr 01, 2024 | 85.72 | 86.12 | 83.67 | 84.79 | 355019.0 |
| Mar 28, 2024 | 83.92 | 85.45 | 83.67 | 85.35 | 593876.0 |
| Mar 27, 2024 | 82.39 | 84.16 | 82.30 | 84.09 | 298230.0 |
| Mar 26, 2024 | 82.33 | 82.53 | 80.88 | 81.64 | 347661.0 |
| Mar 25, 2024 | 80.89 | 82.13 | 80.83 | 81.82 | 483055.0 |
| Mar 22, 2024 | 80.81 | 81.37 | 79.79 | 80.28 | 372066.0 |
| Mar 21, 2024 | 80.10 | 81.23 | 79.55 | 80.29 | 509827.0 |
| Mar 20, 2024 | 77.01 | 80.43 | 76.57 | 79.82 | 666490.0 |
| Mar 19, 2024 | 75.79 | 78.00 | 75.79 | 77.51 | 523908.0 |
| Mar 18, 2024 | 75.19 | 76.13 | 74.62 | 75.79 | 445561.0 |
| Mar 15, 2024 | 75.02 | 75.65 | 72.86 | 74.82 | 899581.0 |
| Mar 14, 2024 | 76.20 | 76.54 | 74.79 | 75.60 | 290464.0 |
| Mar 13, 2024 | 76.90 | 77.82 | 76.29 | 76.34 | 265925.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
43.77
Minimum
Jan 27 2022
139.48
Maximum
Feb 08 2021
87.73
Average
84.96
Median
Jun 22 2020
Price Benchmarks
| Stryker Corp | 332.42 |
| Boston Scientific Corp | 67.81 |
| ResMed Inc | 178.24 |
| Abbott Laboratories | 105.37 |
| Insulet Corp | 169.16 |
Price Related Metrics
| PE Ratio | 34.78 |
| PS Ratio | 3.459 |
| PEG Ratio | 1.055 |
| Price to Book Value | 4.606 |
| Price to Free Cash Flow | 34.12 |
| Earnings Yield | 2.88% |
| Market Cap | 4.345B |
| PEGY Ratio | 1.055 |
| Operating PE Ratio | 24.37 |
| Normalized PE Ratio | 32.81 |